Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases.

Dahbi G, Mora A, López C, Alonso MP, Mamani R, Marzoa J, Coira A, García-Garrote F, Pita JM, Velasco D, Herrera A, Viso S, Blanco JE, Blanco M, Blanco J.

Int J Antimicrob Agents. 2013 Oct;42(4):347-51. doi: 10.1016/j.ijantimicag.2013.06.017. Epub 2013 Aug 29.

PMID:
23992646
2.

Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.

Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J.

J Antimicrob Chemother. 2009 Jun;63(6):1135-41. doi: 10.1093/jac/dkp122. Epub 2009 Apr 7.

3.

Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.

Olesen B, Hansen DS, Nilsson F, Frimodt-Møller J, Leihof RF, Struve C, Scheutz F, Johnston B, Krogfelt KA, Johnson JR.

J Clin Microbiol. 2013 Jun;51(6):1779-85. doi: 10.1128/JCM.00346-13. Epub 2013 Apr 3.

4.

Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.

Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S; Kyoto-Shiga Clinical Microbiology Study Group.

J Antimicrob Chemother. 2012 Nov;67(11):2612-20. doi: 10.1093/jac/dks278. Epub 2012 Jul 26.

5.

Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J; Spanish Group for Nosocomial Infections (GEIH).

J Clin Microbiol. 2013 Oct;51(10):3358-67. doi: 10.1128/JCM.01555-13. Epub 2013 Aug 7.

6.

Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain.

Mora A, Blanco M, López C, Mamani R, Blanco JE, Alonso MP, García-Garrote F, Dahbi G, Herrera A, Fernández A, Fernández B, Agulla A, Bou G, Blanco J.

Int J Antimicrob Agents. 2011 Jan;37(1):16-21. doi: 10.1016/j.ijantimicag.2010.09.012. Epub 2010 Nov 13.

PMID:
21075606
7.

Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.

Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec JY, Rafignon G, Bruno P, Mora A, Lopez C, Dahbi G, Dunais B, Anastay M, Branger C, Moreau R, Pradier C, Nicolas-Chanoine MH.

J Antimicrob Chemother. 2014 May;69(5):1231-7. doi: 10.1093/jac/dkt519. Epub 2014 Jan 8.

8.

Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.

Dahbi G, Mora A, Mamani R, López C, Alonso MP, Marzoa J, Blanco M, Herrera A, Viso S, García-Garrote F, Tchesnokova V, Billig M, de la Cruz F, de Toro M, González-López JJ, Prats G, Chaves F, Martínez-Martínez L, López-Cerezo L, Denamur E, Blanco J.

Int J Med Microbiol. 2014 Nov;304(8):1247-57. doi: 10.1016/j.ijmm.2014.10.002. Epub 2014 Oct 14.

PMID:
25455219
9.

Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates.

Mora A, Herrera A, Mamani R, López C, Alonso MP, Blanco JE, Blanco M, Dahbi G, García-Garrote F, Pita JM, Coira A, Bernárdez MI, Blanco J.

Appl Environ Microbiol. 2010 Nov;76(21):6991-7. doi: 10.1128/AEM.01112-10. Epub 2010 Sep 3.

10.

National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Blanco JE, Alonso MP, García-Garrote F, Chaves F, Orellana MÁ, Martínez-Martínez L, Calvo J, Prats G, Larrosa MN, González-López JJ, López-Cerero L, Rodríguez-Baño J, Pascual A.

J Antimicrob Chemother. 2011 Sep;66(9):2011-21. doi: 10.1093/jac/dkr235. Epub 2011 Jun 13.

11.

Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain.

Colomer-Lluch M, Mora A, López C, Mamani R, Dahbi G, Marzoa J, Herrera A, Viso S, Blanco JE, Blanco M, Alonso MP, Jofre J, Muniesa M, Blanco J.

J Antimicrob Chemother. 2013 Apr;68(4):758-65. doi: 10.1093/jac/dks477. Epub 2012 Dec 7.

12.

Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.

Zhong YM, Liu WE, Liang XH, Li YM, Jian ZJ, Hawkey PM.

J Antimicrob Chemother. 2015 Aug;70(8):2223-7. doi: 10.1093/jac/dkv114. Epub 2015 May 9.

13.

Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.

Brisse S, Diancourt L, Laouénan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentré F, Jarlier V, Nicolas-Chanoine MH; Coli β Study Group.

J Clin Microbiol. 2012 Sep;50(9):2974-81. Epub 2012 Jul 3.

14.

Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.

Birgy A, Mariani-Kurkdjian P, Bidet P, Doit C, Genel N, Courroux C, Arlet G, Bingen E.

J Clin Microbiol. 2013 Jun;51(6):1727-32. doi: 10.1128/JCM.03255-12. Epub 2013 Mar 20.

15.

Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.

Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S.

J Antimicrob Chemother. 2010 Apr;65(4):651-60. doi: 10.1093/jac/dkq004. Epub 2010 Jan 29.

16.

Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.

Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS 2nd, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA; AMERECUS Investigators.

Antimicrob Agents Chemother. 2012 May;56(5):2364-70. doi: 10.1128/AAC.05824-11. Epub 2012 Feb 21.

17.

Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain).

Coelho A, Mora A, Mamani R, López C, González-López JJ, Larrosa MN, Quintero-Zarate JN, Dahbi G, Herrera A, Blanco JE, Blanco M, Alonso MP, Prats G, Blanco J.

J Antimicrob Chemother. 2011 Mar;66(3):517-26. doi: 10.1093/jac/dkq491. Epub 2010 Dec 21.

18.
19.

Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.

Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP.

J Antimicrob Chemother. 2008 Aug;62(2):284-8. doi: 10.1093/jac/dkn181. Epub 2008 May 2.

20.

Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.

Matsumura Y, Nagao M, Iguchi M, Yagi T, Komori T, Fujita N, Yamamoto M, Matsushima A, Takakura S, Ichiyama S.

Clin Microbiol Infect. 2013 Feb;19(2):161-8. doi: 10.1111/j.1469-0691.2012.03762.x. Epub 2012 Feb 14.

Items per page

Supplemental Content

Write to the Help Desk